American National Insurance’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

American National Insurance’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-86,545	Closed	-$60K	–	356
2020 Q4	$60K	Hold	86,545	–	–	﹤0.01%	346
2020 Q3	$195K	Hold	86,545	–	–	0.01%	320
2020 Q2	$310K	Hold	86,545	–	–	0.02%	300
2020 Q1	$329K	Hold	86,545	–	–	0.02%	270
2019 Q4	$261K	Buy	+86,545	New	+$225K	0.01%	305

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

American National Insurance's BMY.RT Position: Q1 2021 in Review

American National Insurance sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 86,545 shares — an estimated $60K sold.

American National Insurance first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $329K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

American National Insurance reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
American National Insurance sold 86,545 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $60K.
American National Insurance first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
American National Insurance's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $329K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on American National Insurance's 13F filing for Q1 2021, filed 13 May 2021.